Neoplasia endócrina múltipla tipo 1 (NEM1): entenda a síndrome, os sintomas e o acompanhamento

Multiple endocrine neoplasia type 1 (MEN1) is a rare genetic syndrome that can increase the risk of tumors in different hormone-producing glands. Receiving this diagnosis or discovering cases in the family often generates many questions, but understanding the condition is an important step towards safer and more informed follow-up. In this video, you will understand what MEN1 is, why it happens, what symptoms may arise throughout life, and how the recommended monitoring for people with the syndrome works. 🔍 What you will find in this guide: What is multiple endocrine neoplasia type 1 (MEN1)? Understand how the syndrome affects the endocrine glands and why it is known for the involvement of the parathyroid, pituitary, and pancreas. The relationship between the MEN1 gene and family inheritance Learn how the genetic transmission of the syndrome occurs and why first-degree relatives may benefit from specialized evaluation. Main Symptoms of MEN1 Learn about the most frequent signs related to hyperparathyroidism, pituitary tumors, and neuroendocrine tumors of the pancreas and duodenum. When to suspect the syndrome See which clinical characteristics may lead a doctor to investigate the presence of MEN1. How the diagnosis is made Understand the clinical criteria used and the role of genetic testing in diagnostic confirmation. Genetic testing and family counseling Discover how genetic counseling helps patients and families understand the results and plan follow-up. Lifelong follow-up Learn about the laboratory tests, imaging exams, and periodic evaluations that help in the early detection of changes. Quality of life and current perspectives Understand how structured and multidisciplinary follow-up can contribute to safer and more individualized care. MEN1 is a condition that requires continuous monitoring, but many of its manifestations can be identified early and treated appropriately. Evidence-based information and expert follow-up are fundamental for decision-making throughout life. 👍 Did this content help bring relief and clarify your treatment options? Like and share with patients and family members who also need reliable and up-to-date information. 🔔 Subscribe to the channel to follow more content about neuroendocrine tumors, hereditary syndromes, oncology, and endocrinology with Dr. Hugo Tanaka. Dr. Hugo Tanaka Clinical Oncologist CRM 163241 | RQE 100689 – Clinical Oncology Website: https://drhugotanaka.com.br/